Amundi Asset Management US’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
2020
Q4
$14.6M Sell
2020
Q3
$12.2M Sell
2020
Q2
$20M Sell
2020
Q1
$20M Sell
2019
Q4
$29.1M Sell
2019
Q3
$14.9M Buy
2019
Q2
$17.4M Buy
2019
Q1
$11.5M Buy